Researcher Verification

By entering this website, you confirm that you are a qualified researcher and that all materials are intended strictly for laboratory research purposes.

Products are not intended for human or veterinary use, diagnostic use, or consumption.

FREE SHIPPING OVER $250 · FREE BAC WATER OVER $150

← Back to Products

CJC-1295 / Ipamorelin

Buy 1, Get 1 Free Free vials are automatically matched to every paid vial.

1. Choose Your Dose

2. Choose Quantity

B1G1 SELECT DOSE
Custom Quantity Choose 1–10 paid vials
2 total
2 VIALS 1 + 1 FREE
— — Select dose

We Accept

Description

What researchers study CJC-1295 / Ipamorelin for in women

Combined GHRH + GHRP research is referenced in women’s mid-life studies of sleep quality, body composition, and GH-axis decline that accelerates post-menopause.

Synergistic GH release

Co-administration research demonstrates greater GH amplitude than either peptide alone, with sex-stratified pharmacology referenced in mixed-cohort studies.

Sleep & recovery

Slow-wave sleep, which declines steeply in perimenopause, is a primary endpoint in GH-axis research using this blend.

Body composition

Female pre-clinical models have measured lean mass and adipose redistribution following combined GHRH/GHRP administration.

Selected literature

  • Teichman SL, et al. JCEM 2006 — CJC-1295 pharmacokinetics
  • Raun K, et al. Eur J Endocrinol 1998 — Ipamorelin, the first selective GH secretagogue